CAS Medical Systems (CASM) Reports In-Line Q4 EPS

CAS Medical Systems (NASDAQ: CASM) reported Q4 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the quarter came in at $5.8 million versus the consensus estimate of $5.8 million.

For earnings history and earnings-related data on CAS Medical Systems (CASM) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Change in Nonfarm Payrolls (Aug) 162K vs 55K Expected, Unemployment Rate 4.1%
• StoneX Reiterates Hold Rating on Old Dominion Freight Line (ODFL) on QTD Operating Metrics